HCV Next Topics: Acute HCV, Risk for Head and Neck Cancers,Grazoprevir Plus Ribavirin....

Looking for an End to the Waiting Game in Acute HCV

The following articles appeared in the August print edition of HCV NEXT, available online @ Healio.

Table of Contents
5 Questions
A Conversation With Zarine Shah, MD, MBBS

Cover Story
Looking for an End to the Waiting Game in Acute HCV

Editorial
Universal Testing in an ED Reveals Need for Widespread Implementation

Feature
Beyond HCV: Radiopaque Bead Treatment ‘Potential Game-Changer’ for HCC

In the Journals
Low Viremia, Female Sex Associated With Spontaneous HCV Clearance

Unrestricted Access to HCV Therapy Cost-Effective for Medicaid Beneficiaries

Patient Response to Harvoni Unaffected by Baseline RAS in NS5A

President Obama Outlines Progress, Future of Affordable Care Act

Grazoprevir Plus Ribavirin Linked to Rapid, Sustained Suppression of HCV RNA

HCV Increases Risk for Head and Neck Cancers

Trend Watch
FDA Approves Viekira XR for HCV Genotype 1

AASLD, CCO Introduce Interactive HCV Program for Providers

Universal ED Screening Detects Unrecognized HCV at UAB Hospital

FDA Places RG-101 for HCV on Clinical Hold